This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Monday's Small-Cap Winners & Losers

Gevity HR (GVHR), a human-resources services firm, sustained one of the biggest price drops in the small-cap sector Monday.

Shares of the Brandenton, Fla., company plunged 34.7% after third-quarter earnings slid by nearly three-quarters to $2.5 million, or a dime a share, on falling revenue of $146.5 million. Analysts polled by Thomson Financial were seeking 13 cents a share on revenue of $153.1 million. Shares were down $3.27 to $6.15.

K-Swiss (KSWS) was also among the small-cap losers after Merrill Lynch downgraded the footwear maker to neutral. Shares of the Westlake Village, Calif.-based company were off $1.41, or 6.4%, to $20.51.

Biotech firm Cambrex (CBM - Get Report) was also kicked lower by a downgrade. An analyst at Longbow lowered the New Jersey company's rating to neutral from buy following last week's report of a widened third-quarter loss. Shares shed 4.8% to $10.02.

All three of the above stocks helped to drag on both the Russell 2000, off 0.9% to 790.44, and the S&P SmallCap 600, which was sinking 1% to 409.66.

Elsewhere, Favrille (FVRL) tumbled 14.5% to $2.42 on late Friday's announcement of an equity offering. The San Diego biopharma agreed to sell $21.1 million worth of "units" primarily to institutional investors, with each to contain one share and a warrant to purchase 0.6 shares for a $2.77 exercise price. That comes to a total of 7.4 million shares and warrants to purchase about 4.4 million more.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BLDP $1.42 0.00%
CBM $48.60 -1.50%
MFLX $23.00 -0.26%
AAPL $94.19 -1.04%
FB $118.06 0.54%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs